Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- CHRISTIE A. The disease spectrum of human histoplasmosis. Ann Intern Med. 1958 Sep;49(3):544–555. doi: 10.7326/0003-4819-49-3-544. [DOI] [PubMed] [Google Scholar]
- Christie A., Peterson J. C. Pulmonary Calcification in Negative Reactors to Tuberculin. Am J Public Health Nations Health. 1945 Nov;35(11):1131–1147. doi: 10.2105/ajph.35.11.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DAY R. Experimental ocular histoplasmosis. Am J Ophthalmol. 1949 Oct;32(10):1317–1330. doi: 10.1016/s0002-9394(49)91750-x. [DOI] [PubMed] [Google Scholar]
- FOSTER J. B., ALMEDA E., LITTMAN M. L., WILSON M. E. Some intraocular & conjunctival effects of amphotericin B in man and in the rabbit. AMA Arch Ophthalmol. 1958 Oct;60(4 Pt 1):555–564. doi: 10.1001/archopht.1958.00940080573005. [DOI] [PubMed] [Google Scholar]
- GREENDYKE R. M., KALTREIDER N. L. Chronic histoplasmosis; report of a patient successfully treated with amphotericin B. Am J Med. 1959 Jan;26(1):135–138. doi: 10.1016/0002-9343(59)90333-x. [DOI] [PubMed] [Google Scholar]
- HARRELL E. R., CURTIS A. C. The treatment of North American blastomycosis with amphotericin B. AMA Arch Derm. 1957 Nov;76(5):561–569. doi: 10.1001/archderm.1957.01550230025004. [DOI] [PubMed] [Google Scholar]
- KRAUSE A. C., HOPKINS W. G. Ocular manifestation of histoplasmosis. Am J Ophthalmol. 1951 Apr;34(4):564–566. doi: 10.1016/0002-9394(51)90300-5. [DOI] [PubMed] [Google Scholar]
- LEHAN P. H., YATES J. L., BRASHER C. A., LARSH H. W., FURCOLOW M. L. Experiences with the therapy of sixty cases of deep mycotic infections. Dis Chest. 1957 Dec;32(6):597–614. doi: 10.1378/chest.32.6.597. [DOI] [PubMed] [Google Scholar]
- LITTMAN M. L., HOROWITZ P. L., SWADEY J. G. Coccidioidomycosis and its treatment with amphotericin B. Am J Med. 1958 Apr;24(4):568–592. doi: 10.1016/0002-9343(58)90297-3. [DOI] [PubMed] [Google Scholar]
- LOURIA D. B. Some aspects of the absorption, distribution, and excretion of amphotericin B in man. Antibiotic Med Clin Ther (New York) 1958 May;5(5):295–301. [PubMed] [Google Scholar]
- MILLER J. M., GINSBERG M., JOHNSON H. R., BOGOSIAN A. The treatment of histoplasmosis with amphotericin B (fungizone). Antibiotic Med Clin Ther (New York) 1958 Oct;5(10):593–597. [PubMed] [Google Scholar]
- SALVIN S. B., FURCOLOW M. L. Precipitins in human histoplasmosis. J Lab Clin Med. 1954 Feb;43(2):259–274. [PubMed] [Google Scholar]
- SEABURY J. H., DASCOMB H. E. Experience with amphotericin B for the treatment of systemic mycoses. AMA Arch Intern Med. 1958 Dec;102(6):960–976. doi: 10.1001/archinte.1958.00260230106014. [DOI] [PubMed] [Google Scholar]
- VOGEL R. A., CRUTCHER J. C. Studies on the bioassay and excretion of amphotericin B in patients with systemic mycoses. Antibiotic Med Clin Ther (New York) 1958 Aug;5(8):501–506. [PubMed] [Google Scholar]
- WILLIAMS R. M., SKIPWORTH G. B. Treatment of disseminated coccidioidomycosis with amphotericin B; report of a case. AMA Arch Derm. 1958 Jul;78(1):97–100. doi: 10.1001/archderm.1958.01560070101019. [DOI] [PubMed] [Google Scholar]